Skip to main content
. 2023 Feb 8;8(3):222–230. doi: 10.1001/jamacardio.2022.5309

Table 1. Characteristics of Participants at ARIC Study Visit 4 According to Past Change in NT-proBNP.

Characteristic Mean (SD)a P value
Total (N = 9776) Visit 2 <125 pg/mL Visit 2 ≥125 pg/mL
Visit 4 <125 pg/mL (n = 6693) Visit 4 ≥125 pg/mL (n = 1744) Visit 4 <125 pg/mL (n = 320) Visit 4 ≥125 pg/mL (n = 1019)
Age, y 62.6 (5.7) 61.8 (5.4) 64.2 (5.6) 62.6 (5.5) 65.3 (5.7) <.001
Women, No. (%) 5523 (56.5) 3453 (51.6) 1088 (62.4) 247 (77.2) 731 (71.7) <.001
Men, No. (%) 4253 (43.5) 3240 (48.4) 655 (37.6) 73 (22.8) 288 (28.3)
Black, No. (%) 2082 (21.3) 1606 (24.0) 260 (14.9) 69 (21.6) 145 (14.2) <.001
White, No. (%) 7694 (78.7) 5087 (76.0) 1484 (85.1) 251 (78.4) 874 (85.8)
Hypertension, No. (%) 4458 (45.6) 2704 (40.4) 991 (56.8) 170 (53.0) 598 (58.7) <.001
Hypertension medication, No. (%) 3353 (34.3) 2035 (30.4) 715 (41.0) 142 (44.4) 470 (46.1) <.001
Blood pressure, mm Hg
Systolic 128.3 (20.1) 126.4 (18.7) 133.3 (21.8) 126.8 (22.4) 132.87 (22.7) <.001
Diastolic 70.0 (9.9) 70.2 (9.6) 70.1 (10.6) 68.8 (10.3) 69.0 (10.7) .04
LDL-C, mg/dL 123.0 (33.3) 124.8 (33.0) 118.8 (32.8) 123.2 (33.6) 117.7 (34.7) <.001
Triglycerides, mg/dL 62.4 (37.9) 62.9 (38.9) 62.4 (35.8) 62.2 (42.1) 59.3 (32.4) .04
Cholesterol-lowering medication, No. (%) 1339 (13.7) 863 (12.9) 270 (15.5) 41 (12.9) 167 (16.4) .001
Diabetes, No. (%) 1506 (15.4) 1084 (16.2) 263 (15.1) 46 (14.5) 114 (11.2) .001
Blood glucose, mg/dL 1980.2 (663.1) 2012.6 (699.1) 1922.5 (591.0) 1958.6 (652.3) 1873.9 (499.1) <.001
Body mass indexb 28.7 (5.5) 28.9 (5.3) 28.3 (5.6) 28.8 (6.0) 27.4 (5.8) <.001
eGFR, mL/min/1.73m2 86.1 (16.3) 88.5 (15.1) 81.7 (17.1) 83.6 (15.7) 78.4 (18.4) <.001
Current smoking, No. (%) 1408 (14.4) 910 (13.6) 277 (15.9) 60 (18.6) 164 (16.1) .003
Prevalent coronary heart disease, No. (%) 694 (7.1) 315 (4.7) 188 (10.8) 23 (7.3) 166 (16.3) <.001

Abbreviations: ARIC, Atherosclerosis Risk in Communities; eGFR, estimated glomerular filtration rate; LDL-C, low-density lipoprotein cholesterol; NT-proBNP, N-terminal pro–B-type natriuretic peptide.

SI conversion factors: To convert cholesterol to millimoles per liter, multiply by 0.0259; glucose to millimoles per liter, multiply by 0.0555; NT-proBNP to nanograms per liter, multiply by 1; triglycerides to millimoles per liter, multiply by 0.0113.

a

Continuous variables expressed as means (SDs) and compared using analysis of variance. Categorical variable expressed as percentages and compared using χ2 test.

b

Body mass index is calculated as weight in kilograms divided by height in meters squared.